BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31803175)

  • 1. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.
    Löffler MW; Nussbaum B; Jäger G; Jurmeister PS; Budczies J; Pereira PL; Clasen S; Kowalewski DJ; Mühlenbruch L; Königsrainer I; Beckert S; Ladurner R; Wagner S; Bullinger F; Gross TH; Schroeder C; Sipos B; Königsrainer A; Stevanović S; Denkert C; Rammensee HG; Gouttefangeas C; Haen SP
    Front Immunol; 2019; 10():2526. PubMed ID: 31803175
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
    Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
    Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor.
    Shi L; Chen L; Wu C; Zhu Y; Xu B; Zheng X; Sun M; Wen W; Dai X; Yang M; Lv Q; Lu B; Jiang J
    Clin Cancer Res; 2016 Mar; 22(5):1173-1184. PubMed ID: 26933175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.
    Hansler J; Wissniowski TT; Schuppan D; Witte A; Bernatik T; Hahn EG; Strobel D
    World J Gastroenterol; 2006 Jun; 12(23):3716-21. PubMed ID: 16773688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.
    Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Ueda T; Arihara F; Kagaya T; Yamashita T; Fushimi K; Kaneko S
    Hepatology; 2013 Apr; 57(4):1448-57. PubMed ID: 23174905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer.
    Ito F; Ku AW; Bucsek MJ; Muhitch JB; Vardam-Kaur T; Kim M; Fisher DT; Camoriano M; Khoury T; Skitzki JJ; Gollnick SO; Evans SS
    PLoS One; 2015; 10(11):e0143370. PubMed ID: 26599402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
    Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
    Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
    White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
    Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
    Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
    Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.
    Lee BC; Lee HG; Park IJ; Kim SY; Kim KH; Lee JH; Kim CW; Lee JL; Yoon YS; Lim SB; Yu CS; Kim JC
    Medicine (Baltimore); 2016 Sep; 95(39):e4999. PubMed ID: 27684857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
    Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
    Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
    Mazzaferro V; Coppa J; Carrabba MG; Rivoltini L; Schiavo M; Regalia E; Mariani L; Camerini T; Marchianò A; Andreola S; Camerini R; Corsi M; Lewis JJ; Srivastava PK; Parmiani G
    Clin Cancer Res; 2003 Aug; 9(9):3235-45. PubMed ID: 12960108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
    Abitabile P; Hartl U; Lange J; Maurer CA
    Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
    Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.
    Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P
    Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of local ablation therapy for liver metastases from colorectal cancer using radiofrequency ablation and microwave coagulation therapy (RFA/MCT)].
    Yoshitani S; Hayashi K; Kuroda M; Tanaka Y; Hasegawa T; Saito H; Kosaka T; Takashima S
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1666-9. PubMed ID: 16315903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases.
    Stintzing S; Grothe A; Hendrich S; Hoffmann RT; Heinemann V; Rentsch M; Fuerweger C; Muacevic A; Trumm CG
    Acta Oncol; 2013 Jun; 52(5):971-7. PubMed ID: 23409768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.